LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 1,862 pages found matching %3Cscript%3Ealert%28%27What_Security?%27%29%3C/script%3E- Green Card Disconnect
Nov-2-06 Spokane, WA " Immigration says my application for citizenship is being held up by the FBI pending a name search but I had an interview 18 months ago and was issued a conditional green card," says Fahd Mohiuebin. "I think the FBI is holding my file because my first name is Arabic." Fahd's wife is a U.S. citizen and a Caucasian, and Fahd is Indian... - Accutane: Depression, Suicide and Degenerative Diseases
Feb-7-08 Chicago, IL The tendency of some patients to become depressed and to exhibit suicidal behavior while taking Accutane (isotretinoin), is once again in the limelight. Friday, former Chicago Bull's cheerleader Kim Smith filed a lawsuit against Hoffmann-La Roche, the manufacturer of Accutane, in which she claims Accutane left her in a dark depression... - California Drywaller Sued for Denying Breaks and Overtime Pay
Feb-6-08 Los Angeles, CA: Edmund G. Brown, the California Attorney General is suing one of the largest drywall contractors in Los Angeles, Interwell Development Systems, for "cheating" hundreds of their employees out of approximately $5 million in benefits and wages. Interwall employed what Brown calls, "a sophisticated and heartless scheme" that involved severa... - Big Pharma Bankrupting US Health Care System
Aug-29-06 ig Pharma is bankrupting the nation's health care system by convincing prescribing doctors to over-medicate patients with expensive psychiatric drugs and then send the bills to government programs like Medicaid and Medicare. The peddling of the new generation of psychiatric drugs that include the selective serotonin reuptake inhibitors antidepressants (S... - Zetia/Vytorin: What Did They Know and When Did They Know It?
Feb-3-08 Kenilworth, NJ: The scandal over Merck/Schering-Plough's long delay in releasing the results of the ENHANCE tests of its big-bucks anti-cholesterol medication Vytorin continues to grow—to the extent that The Wall Street Journal now calls it "Vytoringate". And like its predecessor scandal, the focus of investigations has come down to a simple question: Wh... - Feds Crack Down on Medical Device Implant For Profit Industry - Part II
Nov-14-07 Washington: DC: To settle criminal charges of conspiring to violate the federal anti-kickback statute by using consulting agreements as inducements for orthopedic surgeons to use a company's products, four device makers recently entered into deferred prosecution agreements with the Department of Justice and agreed to pay a total of $311 million. The com... - California Supreme Court Clarifies Reach of California Labor Code
Jul-13-20 San Francisco, CA On June 29, the California Supreme Court handed down a pair of opinions that clarify the application of the California labor code to employees who work both within and outside of the state. Ward v. United Airlines, Inc. stands broadly for the proposition that the California labor code applies to employees if the employee... - Feds Crack Down on Medical Device Implant For Profit Industry - Part I
Nov-12-07 Washington, DC: On September 27, 2007, criminal complaints were filed against four device makers, charging the companies with conspiring to violate the federal anti-kickback statute by using consulting agreements with orthopedic surgeons as inducements to use a company's artificial hip and knee replacement and reconstruction products. The anti-kickback... - Kadant Composites LLC is Dead, but Kadant Inc. is Thriving
Nov-28-07 Westford, MA Since news spread that Kadant Composites had recalled certain lots of their GeoDeck composite decking due to deterioration, disgruntled consumers have been posting their stories and frustrations online for the entire world to see. Their stories seem to have a familiar ring: decks proudly built with this new, environmentally friendly pro... - Congressmen on War Path over FDA approval of Ketek
Jun-12-06 French drug giant Sanofi-Aventis has stopped enrolling pediatric patients in clinical trials for Ketek. On June 9, 2006, the drug maker said it halted tests on its own to ensure that trials of the drug complied with FDA requirements. The company denied that the studies were suspended because of safety concerns. However, the move jives with the recently in... - Medtronic Sprint Fidelis Leads: Thirty-Two Shocks in Forty Minutes
Nov-19-07 Cold Brook, NY: Thomas Bergstrom is lucky to be alive. On June 28, 2007, his Medtronic defibrillator administered thirty-two shocks to his heart in forty minutes. The reason his defibrillator administered the shocks is that his Medtronic Sprint Fidelis Leads had fractured, sending an improper signal to his defibrillator. Unfortunately for Bergstrom, th... - Add Triaminic Vapor Patch To List Of Dangerous Patches
Jun-25-06 On June 19, 2006, Novartis Consumer Health issued a recall for the cough-suppressing Triaminic Vapor Patches in the US, about three weeks after Health Canada issued a warning after a Canadian child who chewed on a patch suffered a seizure. There have been eight adverse events with the patch, all involving ingestion, Navartis spokesperson, Julie Masow, tol... - Whistleblower Mark Livingston Battles Wyeth Pharmaceuticals
May-10-06 Washington DC Attorney, Jason Zuckerman, says a positive result of the recent corporate scandals is the recognition of the value of whistleblowers in exposing fraud, corruption, and other wrongdoing within a company. As a result of a shift in the public's perception, he says, some whistleblowers are viewed as heroes for taking on powerful corporations lik... - Zyprexa: In the Drug Business, the Gain is Worth the Risk
Oct-26-07 Indianapolis, IN Eli Lilly knew that there were problems with Zyprexa from the very beginning. But even amidst a flurry of personal injury lawsuits, and the revelation of risk factors for diabetes and other metabolic complications, Zyprexa has grown to become a huge profit center for its manufacturer. And while one hand warns of dire side effects, t... - Kids Dying From Off-Label Use Of Antipsychotics
May-5-06 A recent USA Today sponsored review of the FDA database from 2000 to 2004 found at least 45 deaths in children under 18 with atypical antipsychotics listed as the "primary suspect," and 1,328 reports of other serious side effects, some life-threatening. Atypical antipsychotics are a relatively new class of drugs approved by the FDA for the treatment of a... - Ex-Pfizer VP Peter Rost Takes On Goliath
May-9-06 Beginning in 1997, Pharmacia, currently a subsidiary of Pfizer, sought to boost its sales of the drug Genotropin. To that end, the company illegally marketed the drug to spur growth in short children and as an anti-aging drug for adults looking for the fountain of youth. In a nutshell, the off-label marketing scheme included: (1) direct payments to doct... - It's Time To Sue Doctors Who Prescribe Drugs Off-Label Part I
Aug-15-07 Washington, DC: Critics say the tens of thousands of lawsuits filed against the drug giants have had little impact when it comes to dismantling the off-label drug marketing schemes and therefore, there needs to be an all out campaign of highly publicized lawsuits filed against the doctors serving as middle man pushers, one by one by one. It is illegal... - Employment Discrimination, Disability Accommodations and Return to Work after COVID-19 Closures
Jun-10-20 New York, NY Vincent White, a partner at White, Hilferty and Albanese, hears stories like this frequently now: An employee at a New York financial services firm wants to continue to work from home even after the rest of the sales operation returns to the office. His serious heart condition raises the risks associated with exposure to COVID-19, but... - Vaccinating For Profit - From Cradle to Coffin
Feb-2-06 Due to the flooding of special education classrooms, along with the rising medical costs of treating injured children, local taxes will soon go through the roof, at which time the public will be forced to face the unthinkable truth about the poisoned generation. And when that happens, government officials had better not even think about trying to feign i... - Merck has no Plan to pay Vioxx Victims
Apr-30-07 Newark, NJ: In 2006, Merck spent $500 million, including $175 million in the fourth quarter, in legal defense costs worldwide related to Vioxx litigation, according to SEC filings. In addition, after reviewing actual costs and estimating future costs, the company says it has recorded a charge of $75 million to increase the reserve for future defense c...